15.04
-0.16
(-1.05%)
At close: January 31 at 4:00:02 PM EST
14.60
-0.44
(-2.93%)
After hours: 7:59:25 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AUWAERTER PAUL GISBERT Director | Purchase | Oct 6, 2023 | 5,000 |
| AVAT XAVIER Former | Sale | Apr 17, 2023 | 0 |
| BERGMANN ANTHONY Chief Financial Officer | Stock Award(Grant) | Jan 2, 2025 | 5,723 |
| COLLIER EARL M JR Director | Conversion of Exercise of derivative security | Apr 23, 2024 | 56,856 |
| KRASNEY KAREN General Counsel | Conversion of Exercise of derivative security | Dec 13, 2024 | 28,047 |
| LITVACK FRANK I Director | Conversion of Exercise of derivative security | Dec 3, 2024 | -- |
| MANZO LOUIS Director | Conversion of Exercise of derivative security | Feb 21, 2023 | 62,147 |
| MARBAN LINDA Chief Executive Officer | Conversion of Exercise of derivative security | May 12, 2023 | 198,604 |
| MUSKET DAVID B Director | Conversion of Exercise of derivative security | Aug 7, 2024 | 88,788 |
| NIPPON SHINYAKU CO., LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 20, 2024 | 7,090,350 |
Related Tickers
CADL Candel Therapeutics, Inc.
7.07
+1.58%
MESO Mesoblast Limited
20.14
+3.18%
ATRA Atara Biotherapeutics, Inc.
8.88
+4.59%
VRNA Verona Pharma plc
57.30
+0.10%
SRPT Sarepta Therapeutics, Inc.
113.72
-0.64%
EWTX Edgewise Therapeutics, Inc.
28.02
+0.07%
ATYR aTyr Pharma, Inc.
3.8600
+3.21%
CRMD CorMedix Inc.
10.27
-6.38%
AVXL Anavex Life Sciences Corp.
9.27
-3.13%
WVE Wave Life Sciences Ltd.
11.57
-4.06%